🧪 Clinical Trials
Canadian trials recruiting for dementia and Alzheimer's, with eligibility explained in plain language.
CLARITY AD Extension — Lecanemab Long-Term Safety Study
Recruiting Phase: Phase 3 Extension 📍 Toronto ON, Vancouver BC, Montreal QC Sponsor: Eisai / Biogen
Eligibility: Adults aged 50-90 with early Alzheimer's disease (MCI or mild dementia stage). Must have completed or be eligible for the original CLARITY AD trial. Confirmed amyloid pathology required.
Full details & how to apply →